Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1633]
News [6491]
Articles [98]
Editorials [4]
Conferences [184]
elearning [21]
Editor's Choice for June 2016
Prof Gordon McVie - ecancer Editor in Chief
Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )
29 Jun 2016
Mutations associated with imatinib response in CML
Katerina Machova Polakova - Institute of Hematology and Blood Transfusion...
Mutations associated with imatinib response in CML ( Katerina Machova Polakova - Institute of Hematology and Blood Transfusion, Prague, Czech Republic )
20 Jun 2016
Latest in precision cancer medicine
Prof Richard Schilsky - Chief Medical Officer, ASCO
Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )
15 Jun 2016
CD19 CAR T-cells effective with with low dose chemotherapy.
Dr Stephanie Goff - National Cancer Institute, Bethesda, USA
CD19 CAR T-cells effective with with low dose chemotherapy. ( Dr Stephanie Goff - National Cancer Institute, Bethesda, USA )
12 Jun 2016
Specific mutations in leukaemia patients' blood predicts survival
Dr Klaus Metzeler - University of Munich, Munich, Germany
Specific mutations in leukaemia patients' blood predicts survival ( Dr Klaus Metzeler - University of Munich, Munich, Germany )
12 Jun 2016
Causes and consequences of microRNA dysregulation in cancer
Prof Carlo Croce - Ohio State University, Columbus, USA
Causes and consequences of microRNA dysregulation in cancer ( Prof Carlo Croce - Ohio State University, Columbus, USA )
12 Jun 2016
Sequencing multiple myeloma reveals a complex landscape of genetic lesions
Dr Niccolo Bolli - University of Milan, Milan, Italy
Sequencing multiple myeloma reveals a complex landscape of genetic lesions ( Dr Niccolo Bolli - University of Milan, Milan, Italy )
12 Jun 2016
Results from SCHOLAR-1 trial for DLBCL patients
Prof Christian Gisselbrecht - LYSARC, Pierre-Bénite, France
Results from SCHOLAR-1 trial for DLBCL patients ( Prof Christian Gisselbrecht - LYSARC, Pierre-Bénite, France )
12 Jun 2016
Super-enhancer analysis reveals subtypes in AML and MDS
Dr Michael McKeown - Syros Pharmaceuticals, Cambridge, USA
Super-enhancer analysis reveals subtypes in AML and MDS ( Dr Michael McKeown - Syros Pharmaceuticals, Cambridge, USA )
12 Jun 2016
PD-1 enhances elotuzumab efficacy
Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA
PD-1 enhances elotuzumab efficacy ( Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA )
12 Jun 2016
Better screening programmes needed for haematological malignancies such as...
Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany
Better screening programmes needed for haematological malignancies such as leukaemia ( Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany )
12 Jun 2016
Novel therapies for older patients with AML and MDS
Prof Naval Daver - MD Anderson Cancer Center, Houston, United States
Novel therapies for older patients with AML and MDS ( Prof Naval Daver - MD Anderson Cancer Center, Houston, United States )
12 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation